gene expression profiling

DIAGNOSTIC_TEST3 trials

Sponsors

Kyoto University, Mario Boccadoro, Case Comprehensive Cancer Center

Conditions

Bladder CancerMalignant MelanomaMultiple Myeloma

Early Phase 1

Prevention of Recurrence and Metastasis in Genetically High-Risk Melanomas

WithdrawnNCT04285749

Case Comprehensive Cancer CenterMalignant Melanoma

Start: 2020-11-06End: 2021-04-01Updated: 2020-07-27

Phase 2

Gene Expression Profiling in Patients With Invasive Bladder Cancer Receiving Methotrexate, Vinblastine, Doxorubicin, and Cisplatin

TerminatedNCT00516750

Kyoto UniversityBladder Cancer

Start: 2007-07-31End: 2009-02-28Target: 100Updated: 2013-07-10

Unknown Phase

Validation of a Personalised Medicine Tool for Multiple Myeloma That Predicts Treatment Effectiveness in Patients

CompletedNCT03409692

Mario BoccadoroMultiple Myeloma

Start: 2017-06-14End: 2022-07-25Updated: 2023-06-29